verified SJR 1,123 · Q1 • database Scopus / SJR & Web of Science indexed

United Kingdom · Wiley-Blackwell Publishing L...

workspace_premium Q1 — Infectious Diseases lock_open Open Access

HIV Medicine

HIV Medicine is a journal indexed in SJR in Infectious Diseases and Health Policy with an H index of 88. It has a price of 2500 €. It has an SJR impact factor of 1,123 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,123.

HIV Medicine focuses its scope in these topics and keywords: hiv, hivinfected, hepatitis, cohort, adults, virus, risk, care, cardiovascular, maxillofacial, ...

ISSN: 1464-2662

Publisher: Wiley-Blackwell Publishing Ltd

Category: Infectious Diseases

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,123 Q1

H-index 88

Acceptance rate pie_chart

26% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

2.500 € Open Access

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,123

H-index

Docs (year)

142

Docs 3y

389

Total refs

5419

Cites 3y

1159

Citable 3y

360

Cites/Doc 2y

3.16

Ref/Doc

38.16

Immediate OA

2500 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

024 Mortality in the HAART era

XIII World AIDS Conference

Chronic erosive herpes simplex virus infection of the penis, a possible immune reconstitution disease

Changing treatment patterns among patients with HIV: Royal Free Hospital 1987-97

Cardiovascular disease risk factors and antiretroviral therapy in an HIV-positive UK population

British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy

An evaluation of low-cost progression markers in HIV-1 seropositive Zambians

Access to care

A simple, once-daily dosing regimen for treating HIV-1 infection in intravenous drug users

A review of ultrasound-guided percutaneous biopsy of the gastrointestinal tract in HIV-infected patients

A prospective, controlled study assessing the effect of lopinavir on amprenavir concentrations boosted by ritonavir

A case of lipodystrophy after the initiation of zidovudine, lamivudine and efavirenz in an asymptomatic HIV-1-infected patient

SHOW MORE ARTICLES

09 One-year UK experience of nelfinavir in paediatric HIV-1

010 Quadruple HAART in primary infection: results from QUEST

023 Undiagnosed symptomatic acute HIV infections: a 12-month retrospective analysis of cases in South London

022 A heterosexual outbreak in Doncaster involving subtype B of HIV-1: molecular epidemiology as a supplement to contact tracing

021 Assessment of thymic activity by positron emission tomography in HIV patients on HAART

020 Antibody responses to HIV Gag and Env following highly active antiretroviral therapy (HAART)

017 A prospective study of lipid metabolism in HIV-1-seropositive patients treated with HAART

016 Type III hyperlipidaemia, related to PI treatment, is not caused by homozygosity for apoE2

015 Rapid onset lipodystrophy syndrome (LD) in three patients with prior severe nucleoside toxicity

014 Does TB treatment alter virological and immunological response to HAART?

013 Normalization of intestinal permeability following antiretroviral therapy in HIV+ patients with diarrhoea

012 AIDS-related lymphoma in the era of HAART

FAQs

HIV Medicine has an SJR of 1,123 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is 2500 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for HIV Medicine is 26%.

HIV Medicine

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of HIV Medicine?

What is the APC / publication cost?

What is the acceptance rate?